Background
Rheumatoid arthritis (RA) is a chronic, systemic disease characterised by inflammation and gradual destruction of the peripheral joints [1, 2] . It affects up to 1% of the population worldwide and occurs in almost twice as many women as men [2] . While the precise aetiology of the disease is unknown, its clinical course is well understood; joint destruction begins within a few weeks of the onset of symptoms of pain, joint stiffness and/or fatigue.
Involvement of the hands and feet is common. Inflammation of the wrist joint occurs in approximately 75% of RA patients and reduced grip strength and dexterity is frequent [3] . Up to 92% of RA patients experience painful, disabling foot deformities such as hallux valgus, splaying of the forefoot, flattened longitudinal arches and valgus hindfoot [4, 5] . RA patients characteristically display a slow shuffling gait with short strides that lacks the usual heel-toe pattern. These local effects, in conjunction with the general impact of the disease, cause progressive functional impairment that can prevent patients from participating in work, leisure and normal daily living activities [2] ; up to 30% of patients cannot work within 3 years of diagnosis because of RA-associated disability [6] . Consequently, RA is associated with a substantial negative burden on health-related quality of life (HRQL) [1, 7] .
The management of RA targets both the physical and social/psychological aspects of disease. The primary aims of management are to prevent or control joint damage, minimise pain, maintain physical function and improve HRQL through social and psychological support [1, 7] . Non-pharmacological modalities such as exercise therapy or orthotic devices are commonly used in conjunction with pharmacological therapy to maintain symptom control and HRQL in RA patients.
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Cochrane Review conducted in 2000, which found that dynamic exercise therapy effectively increased aerobic capacity and muscle strength in patients with RA, with no detrimental effects on disease activity or pain [9] . To date, however, there have been few clinical studies evaluating the effects of exercise therapy on disease progression, and it is unclear whether dynamic exercise has any impact on functional ability or radiological progression of RA.
Similarly, despite extremely limited data on the efficacy of orthotic devices, it is standard practice to prescribe foot orthoses or specialised footwear in RA patients with the aims of stabilising joints, improving foot positioning and function and reducing pain, stiffness and swelling [7] . Wrist splints may be used to improve patients' abilities to grasp and manipulate objects [3] ; a recent Cochrane review reported that provision of splints effectively improves pain in RA patients [10] .
Review of the evidence
This review examines current evidence for the efficacy of exercise therapy and orthotic interventions in the treatment of RA. For exercise therapy studies, we evaluated the effect of treatment on clinical outcomes such as disease progression, where available, or subjective assessments of HRQL and functional impairment. For studies of orthotic devices, we focused on those evaluating the impact of device use on subjective assessments of pain, HRQL and functional impairment and, for studies in patients with foot deformity, assessments of device use on gait.
Search strategy
English language articles published in the last 10 years were searched in November 2007 using Medline (1997 to date), Embase (1997 to date), the Cochrane Library (1997 to date) and Odyssey (a proprietary database of Wolters Kluwer Health). Search terms were: 'arthritis, rheumatoid' AND ('orthotic devices OR 'exercise therapy' OR 'hydrotherapy'). Additional studies fitting the search criteria were obtained by searching the reference lists of key papers.
Inclusion/exclusion criteria
For studies of exercise therapy, only fully-published, randomised, controlled trials (RCTs) conducted in RA patients were included. Studies using healthy volunteers as controls were excluded. Studies of aerobic exercise interventions were included if the exercise programmes incorporated exercise of at least moderate intensity (60-80% of maximum heart rate) during at least 20 min, performed at least twice per week for at least 6 weeks. Systematic reviews and meta-analyses of fullypublished RCTs meeting these criteria were included where available. RCTs with a mixed population of patients with RA and osteoarthritis were included if results were reported separately for each patient group. For studies of orthotic devices, we included randomised studies in at least 15 patients in which a control device or a crossover design was employed.
Data extraction and synthesis
Data on the effects of the use of physical therapy or orthotic devices on clinical outcomes in patients with rheumatoid arthritis were extracted. The results obtained are presented narratively.
Results

Exercise therapy
Six RCTs of land-based exercise therapy (Table 1 ) [11] [12] [13] [14] [15] [16] and 2 RCTs of hydrotherapy (Table 2 ) [17, 18] met our inclusion criteria. Data from a systematic review of RCTs of the effects of aerobic exercise on patients with RA were included [19] , along with data from a Cochrane review of dynamic exercise therapy in RA patients [9] . Additionally, post-hoc analyses [20] [21] [22] of the Rheumatoid Arthritis Patients in Training (RAPIT) study [11] that reported the effects of exercise on disease activity and progression were included.
Among the studies of land-based exercise therapy, there were two trials of aerobic exercise only [12, 16] , one of non-aerobic exercise only [13] , and three studies of combination aerobic plus non-aerobic exercise programmes [11, 14, 15] . Disease activity outcomes were evaluated as a primary or co-primary endpoint in three studies [12, 14, 15] . The study by Van den Ende and colleagues [14] calculated the Disease Activity Score with four variables (DAS4), including the Ritchie Articular Index, 44 swollen joint count, erythrocyte sedimentation rate (ESR), and a visual analogue scale (VAS); the DAS4 was also assessed as a secondary endpoint in the RAPIT trial [11] . The other studies evaluating disease activity as a primary endpoint evaluated total joint count, ESR and C-reactive protein levels [12] or swelling, tenderness or pain with pressure in 70 peripheral joints [15] .
The remaining studies assessed patient-reported physical function and/or HRQL outcomes as primary endpoints [11] [12] [13] 16, 18] . Assessment tools include the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire, the McMaster Toronto Arthritis (MACTAR) Patient Preference Disability Questionnaire and the Health Assessment Questionnaire (HAQ) in the RAPIT study [11] , the 'Quality of life questionnaire for patients with rheumatoid arthritis' [16] , the Arthritis Impact Measurements Scales (AIMS) II subscale [13] and the modified Functional Capacity Evaluation [18] . The study by Neuberger and colleagues assessed the overall symptom score for fatigue, pain and depression based on data from the 14-item Global 
Land-based Exercise
Disease Activity
At worst, aerobic exercise appears to have no effect on disease activity in RA patients [9, 12, 15] . There were no statistically significant improvements or worsening in the number of involved joints after either short-term (12 or 24 weeks) [9, 12] or long-term (1-year) exercise programmes [15] (Table 1) .
Post-hoc analyses of data from the RAPIT trial suggest that any potential improvements in disease activity with exercise are limited to those patients with little or no joint damage at baseline. One analysis found that after 2 years, patients undertaking regular exercise had significantly less radiological damage to joints of the hands and feet (Larsen score for mean increase from baseline in joint damage 3.5 with exercise vs 5.7 with control; p ¼ 0.045) [21] . However, the proportions of patients experiencing joint damage progression over 2 years were significantly higher among patients in the exercise group with extensive damage to large joints (Larsen score > 5) at baseline (45% vs 85%; p < 0.05) [22] . In contrast, similar proportions of patients in the exercise and control groups with little or no joint damage at baseline (Larsen score 5) experienced increases in joint damage (35% vs 36%) [22] .
Overall, the small number of studies assessing disease activity as a primary outcome means that conclusions regarding the effect of exercise therapy on disease progression in RA must be made with caution. Consistent with the conclusions of the Cochrane review [9] , further studies are required to establish the effect of exercise therapy on long-term radiological progression of RA.
Functional Ability and HRQL
Functional ability and HRQL were generally improved with exercise (Table 1) . Compared with controls, there were significantly greater improvements from baseline in symptoms, walk time and grip strength among patients completing a 12-week aerobic exercise programme in the study by Neuberger and colleagues [12] . Similarly, in the RAPIT study, significantly greater improvements in functional ability were observed in patients undertaking high-intensity, weight-bearing exercise versus controls; these benefits were maintained for up to 2 years [11] . The study evaluating non-aerobic hand strengthening and mobilizing exercises reported significant improvements in hand and finger function after exercise (Table 1) [13] .
356 Evidence-based medicine The results of these trials are consistent with the conclusions of the Cochrane review, which found that dynamic exercise therapy was both safe and effective for improving physical function in RA patients [9] . In contrast, the systematic review found that the effect of exercise on pain, physical function and HRQL in RA patients was unclear, based on a lack of effect observed in many studies [19] . Nonetheless, the authors of this review concluded that aerobic exercise of at least moderate intensity conducted at least three times weekly for 30-60 min was recommended in RA patients, along with moderate to hard strengthening exercises 2-3 times per week [19] . Thus, the overall weight of current evidence suggests that interventions comprising regular aerobic exercise of at least moderate intensity and/ or non-aerobic strengthening exercises have a beneficial effect on functional ability and symptoms of fatigue and depression in RA patients.
Hydrotherapy
Hydrotherapy appears to produce improvements in HRQL and functional capacity that are not significantly different from those of land-based exercise ( Table 2 ). The study by Bilberg and colleagues found no significant betweengroup differences with hydrotherapy versus land-based exercise in HRQL measures [17] . In this study, the hydrotherapy group experienced significant improvements from baseline in SF-36 (Short Form 36 HRQL questionnaire) scores for physical functioning (þ9.5; p < 0.001), bodily pain (þ10.7; p < 0.01), vitality (þ12.1; p < 0.01), and physical component dimensions (þ4.8; p < 0.01) and in AIMS II physical (À0.6; p < 0.01) and HAQ score (À0.2; p < 0.05) [17] . Similarly, in the study by Suomi and colleagues, both hydrotherapy and land-based exercise produced similar improvements from baseline in functional capacity and strength in older RA patients (aged 60-79 years) [18] . Although these studies were of insufficient size to demonstrate equivalent efficacy between hydrotherapy and land-based exercise, and were not specifically designed to demonstrate equivalence between the two regimes, the results suggest that there are no major differences in efficacy with hydrotherapy or land-based exercise.
Orthotic devices Foot orthoses
Four randomised studies evaluating the effects of foot orthoses on pain and functionality in RA patients were identified, including three parallel-group trials that utilised control orthotic devices (traditional or usual-care orthoses) [23, 24, 26] and one crossover study [25] (Table 3) . One of the parallel-group studies [26] incorporated a 2-phase design, in which the initial 2-month randomised, controlled, parallel-group trial was followed by a non-randomised, repeated-measures analysis during which control subjects were supplied with orthotic footwear and re-assessed after 2 months.
Efficacy outcomes were pain, assessed using VAS scores, and functionality, which was assessed via patient-reported HRQL assessment tools [23] [24] [25] [26] . These included the Foot Function Index (FFI), a validated questionnaire incorporating a VAS in which patients rate 23 items in three domains (foot pain, disability and functional limitation), the Foot Health Status Questionnaire (FHSA), a validated questionnaire comprising two sections (one with four domains [foot pain, foot function, footwear and general foot health] and one incorporating SF-36 questions on social capacity, general health and vigour), and the Stanford Health Assessment Questionnaire (HAQ), which consists of 20 questions in 8 categories on various tasks of daily living rated on a 4-point scale (0 ¼ without any difficulty; 3 ¼ unable to do) [23] [24] [25] [26] .
Additionally, the effects of foot orthoses on gait and plantar pressures were assessed in two small randomised trials, including one of the above-mentioned randomised studies (n ¼ 30) [26] and a single-use study of palliative orthoses (n ¼ 16) [27] .
Physical function and pain were significantly improved with the use of specialised foot orthoses (Table 3 ) [23] [24] [25] [26] .
The non-randomised repeated-measures analysis supported the results of the randomised, controlled phase of this study, demonstrated significant improvements in physical function, walk pain, stair pain, and pain-free walk time [26] . Significantly lower mean VAS scores for pain were also reported by patients using palliative orthoses in the single-use study evaluating gait (18.87 vs 42.06 without orthotics; p ¼ 0.008) [27] .
The effects of foot orthoses on gait are unclear; although the single-use study reported no improvements on gait with palliative orthoses [27] , the randomised study demonstrated improvements with orthotic footwear in mean normal velocity (6.4 cm/s) and stride length (5.5 cm), and in fast velocity (8.6 cm/s) and stride length (5.8 cm) [p < 0.05 vs baseline for all comparisons] [26] .
Wrist splints
Two randomised, crossover studies evaluating the effects of up to 4 weeks' wrist splint use in RA patients found that splints improved wrist pain and functionality without compromising dexterity (Table 3 ) [3, 28] . The study by Haskett and colleagues reported significant improvements from baseline in pain with only two of the three splint types (Table 3) comparisons] without compromising dexterity [3] . There were no significant differences between the splint types in terms of improvements from baseline in pain or functionality, except that the Rolyan wrist extensor orthosis produced significantly stronger grip than the elastic wrist support ( p ¼ 0.04), and pegboard dexterity was significantly more compromised with the custom leather splint than with the elastic wrist support ( p ¼ 0.03). Thus, this study did not demonstrate superiority of one type of wrist splint over another [3] .
Conclusions
On the basis of the current evidence evaluated in this review, it appears that exercise therapy comprising aerobic exercise and/or strengthening exercises improves functional ability and the symptoms of fatigue and depression in RA patients. This finding supports current British, American and Canadian treatment guideline recommendations that exercise be implemented in conjunction with pharmacological therapy for the management of RA. Similarly, the available evidence suggests that foot orthoses and wrist splints produce substantial improvements in patient-reported pain and physical function and that the long-term use of customised foot orthoses may lead to stability in the ankle joint complex. However, these conclusions must be interpreted cautiously because of the limited number of well designed studies and the small patient populations in many studies. Larger, well-controlled long-term studies are required to fully assess the long-term efficacy of exercise therapy and orthotic devices in the management of RA.
